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Abstract
Autophagy is an essential cellular response which acts to release stored cellular substrates during 
nutrient restriction, and particularly plays key role in the cellular response to amino acid 
restriction. However, there has been limited work testing whether the induction of autophagy is 
required for adaptive metabolic responses to dietary protein restriction in the whole animal. Here, 
we found that moderate dietary protein restriction led to a series of metabolic changes in rats, 
including increases in food intake and energy expenditure, the downregulation of hepatic fatty acid 
synthesis gene expression and reduced markers of hepatic mitochondrial number. Importantly, 
these effects were also associated with an induction of hepatic autophagy. To determine if the 
induction of autophagy contributes to these metabolic effects, we tested the metabolic response to 
dietary protein restriction in BCL2-AAA mice, which bear a genetic mutation that impairs 
autophagy induction. Interestingly, BCL2-AAA mice exhibit exaggerated responses in terms of 
both food intake and energy expenditure, whereas the effects of protein restriction on hepatic 
metabolism were significantly blunted. These data demonstrate that restriction of dietary protein is 
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sufficient to trigger hepatic autophagy, and that disruption of autophagy significantly alters both 
hepatic and whole animal metabolic response to dietary protein restriction.
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1. INTRODUCTION
The liver plays an essential role in maintaining nutrient homeostasis in response to 
fluctuations in nutrient intake, altering metabolic flux and mobilizing stored nutrients in 
order to maintain physiological function during periods of nutrient restriction. Autophagy is 
an essential cellular process which contributes to both the turnover of cellular components 
and damaged organelles (including mitochondria), as well as the response to nutrient 
restriction [1–3]. Hepatic autophagy has recently been linked to disease states, as defects in 
hepatic autophagy lead to mitochondrial dysfunction, insulin resistance, and lipid 
accumulation [4, 5]. Conversely, enhancing autophagy improves metabolism and extends 
lifespan [6, 7]. Thus the induction of hepatic autophagy during nutrient restriction triggers 
beneficial metabolic responses, while damage to this mechanism may contribute to 
metabolic dysfunction in the context of obesity and diabetes.
Dietary protein restriction is known to trigger adaptive changes in both feeding behavior and 
metabolism, and we and others have focused on identifying mechanisms which mediate 
these adaptive responses [8–10]. Considering autophagy’s key role in the cellular response 
to amino acid restriction in vitro, we hypothesized that autophagy might also contribute to 
the response to protein restriction in the whole animal in vivo. Curiously, this question has 
never been tested. Instead, prior in vivo work has principally focused on the induction of 
autophagy during starvation [2], a setting marked by the acute deprivation of all dietary 
nutrients and which therefore confounds the restriction protein with the restriction of energy. 
We therefore assessed the effects of global dietary protein restriction on metabolic responses 
in rats and mice, and use a unique mouse genetic model, BCL2-AAA mice [11], to test 
whether the induction of autophagy contributes to the metabolic responses to protein 
restriction.
2. Methods
2.1 Protein Restriction and Metabolic Phenotyping in Rats
All animal experiments were reviewed and approved by the Pennington Biomedical 
Research Center Institutional Animal Care and Use Committee. Male Sprague Dawley (SD) 
rats (5–7 weeks of age; Harlan Indianapolis, IN) were single housed in standard shoe-box 
cages with a 12:12 light:dark cycle and constant temperature (22–23°C). Animals were 
randomly divided into two dietary treatment groups (N=8 per group) and fed either a low 
protein diet containing 10% casein (LP) or a normal protein control diet containing 20% 
casein (control) formulated and produced by Research Diets (New Brunswick, NJ) [9, 12]. 
Diets were made isocaloric via concurrent changes in carbohydrate content while 
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maintaining a constant fat content. Metabolic phenotyping in rats utilized the PhenoMaster/
LabMaster system (TSE Systems, Chesterfield, MO) within the Animal Phenotyping Core at 
the PBRC. Animals were initially adapted to the control diet in the metabolic chambers for 3 
days before half the animals in each group were transitioned to the LP diet. Animals 
remained in metabolic chambers for the first 7 days of diet exposure, and were then removed 
to their homecage for the final 7 days. Animals had free access to food and water during this 
period. Food consumption was monitored daily and body composition was determined via 
TD-NMR (Bruker Minispec) on the start of experimental diets (Day 0), the final day of 
metabolic analysis (Day 7) and on the day of sacrifice (Day 14). Animals were euthanized 
after 14 days of feeding, and tissues were extracted and snap frozen in liquid nitrogen or 
fixed in 4% paraformaldehyde for later analysis.
2.2 Protein Restriction and Metabolic Phenotyping in Wildtype and BCL2-AAA mice
BCL2-AAA mice were kindly provided by Dr. Beth Levine (UT Southwestern) and were 
developed as described previously [11]. BCL2-AAA and WT mice were single housed in 
standard shoe-box cages with a 12:12 light:dark cycle and constant temperature (22–23°C). 
Animals were randomly divided into two dietary treatment groups (7–8 mice/diet/genotype) 
and fed either a low protein diet containing 5% casein (LP) or a normal protein control diet 
containing 20% casein (control) formulated and produced by Research Diets (New 
Brunswick, NJ) [8]. Mice were initially adapted to the control diet while in metabolic 
chambers (OxyMax/CLAMS, Columbus Instruments), were transitioned to the LP diet while 
in the OxyMax, and remained in the OxyMax for the first 7 days of dietary exposure. 
Afterward mice were returned to standard caging for the final 7 days, and after 14 days on 
diet were sacrificed and tissue collected as described below. Body weight and food intake 
were collected 4-times through the 14 day experiment. Body composition was measured via 
TD-NMR (Bruker Minispec) on the start of experimental diets (Day 0), the final day of 
OxyMax metabolic analysis (Day 7) and on the day of sacrifice (Day 14).
2.3 Quantitative Real Time RT-PCR
Total mRNA was extracted from frozen liver tissue using TRIzol reagent following the 
manufacturer’s protocol (15596018, Invitrogen, Carlsbad, CA). RNA quality and quantity 
was determined by spectrophotometry using a NanoDrop (Thermo Scientific, Wilmington, 
DE). cDNA synthesis was performed with M-MLV reverse transcriptase (M1701, Promega, 
Madison, WI) and mRNA was quantified on the ABI 7900 platform with TaqMan Universal 
PCR Master Mix (4304437, Applied Biosystems, Carlsbad, CA), using the default ABI 
program for amplification conditions. Primer pairs were designed using NCBI Primer-
BLAST with at least one primer spanning an exon-exon boundary. Primer sequences for 
each transcript are provided in Supplemental Table S1. Target gene expression was 
normalized with cyclophilin as the endogenous control and analyzed using a standard curve.
2.4 Western Blot and Ex vivo autophagy flux
For ATG5/12, whole cell lysates were prepared from liver by homogenizing tissue in whole 
cell lysate buffer, followed by sonication and centrifugation [13]. The supernatant from 
centrifugation was used for subsequent Western blotting on a standard 10% SDS-PAGE gel 
in a Bio-Rad electrophoresis system. In all blots, β-actin (Abcam ab8226; Cambridge, UK) 
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was used as an internal control. ATG5 (#8540) antibody was obtained from Cell Signaling 
Technologies (Danvers, MA) and used to detect ATG5 and conjugated ATG5-ATG12 on the 
same membranes.
To assess autophagy flux, fresh mouse liver tissue from each mouse was minced and divided 
into wells containing DMEM +10% FBS with or without lysosomal inhibitors (20 mM 
NH4Cl; 200 μM leupeptin), and incubated at 37°C in 5% CO2 atmosphere for 2 hours. After 
incubation samples were centrifuged (4°C, 5 min, 1000 g) and the supernatant discarded. 
The pellet was washed with ice-cold PBS and centrifuged (4°C, 5 min, 1000 g) and the 
supernatant discarded. The tissue was homogenized in 0.25 M sucrose (pH 7.0) with 
protease inhibitor cocktail tablets (1 tablet/50 ml; Roche) on ice. After centrifugation (4°C, 
10 min, 13,000 g), the supernatant was collected and the protein content was quantified with 
Coomassie Plus (Bradford) Protein Assay Kit (Thermo Scientific) according to the 
manufacturer’s protocol. For SDS-gel electrophoresis, 30 μg protein samples were diluted to 
5x Laemmli sample buffer containing 60 mM Tris-HCl (pH 6.8), 2% (w/v) SDS, 10% (v/v) 
glycerol, 5% (v/v) 2-mercaptoethanol, and 0.01% (v/v) bromophenol blue. The samples 
were heated at 95°C for 5 minutes and electrophoresed through a 4–20% precast 
polyacrylamide gel (Bio-Rad). Proteins were then transferred to 0.2-μm pore size 
nitrocellulose membranes (BioRad). Membranes were blocked with 3% (w/v) bovine serum 
albumin in TBST buffer (20 mM Tris/HCl, 0.9% (w/v) NaCl, 0.05% (v/v) Tween-20 (pH 
7.6) and incubated with the primary antibody against LC3A/B (Cell Signaling, #12741; 
dilution: 1:1000) at 4°C for 12 hours. Membranes were then washed with TBST, incubated 
with the corresponding HRP-conjugated anti-rabbit IgG (1:2000) for 60 minutes at room 
temperature. After washing with TBST, the membranes were transferred to enhanced 
chemiluminescence substrate (Western Lightning-ECL; PerkinElmer Inc.) for 2 minutes and 
exposed to Premium X-Ray Film (F-BX57; Phenix Research Products) for 5 minutes. Bands 
were scanned and quantified using ImageJ 1.47 (Wayne Rasband, National Institutes of 
Health). In all blots, β-actin (Abcam ab8226; Cambridge, UK) was used as an internal 
control. Autophagy flux was calculated with the following equation: sample plus inhibitor 
(LC3A/B 2 / LC3A/B 1) / sample minus inhibitor (LC3A/B 2 / LC3A/B 1).
2.5 Immunostaining and Immunohistochemistry
For immunohistochemistry (IHC), liver was fixed in 4% paraformaldehyde overnight, 
paraffin embedded and sectioned at 5μm. Samples were deparaffinized and treated with 
0.01M sodium citrate buffer with 0.2% Triton-X100 for antigen retrieval. For colocalization 
of autophagy and mitochondrial markers, light chain 3B (LC3B; Abcam ab64781) and 
cytochrome c oxidase subunit IV (COX IV; Abcam ab14744) with goat anti-rabbit IgG FITC 
(Santa Cruz sc-2012) and goat anti-mouse IgG TR (Abcam ab6787) secondary antibodies, 
respectively, were used with the primary antibodies incubated overnight at 4°C and 
secondaries incubated for 2h at room temperature. For oil red O staining, frozen liver was 
sectioned at 10μm, dried at room temperature for 1 h and stained using a NovaUltra Oil Red 
O Stain Kit per the manufacturer’s protocol (IW-3008, IHCWorld, Woodstock, MD). All 
sections were mounted with Vectashield mounting media containing DAPI (H-1200, Vector 
Labs, Burlingame, CA) for visualization of nuclei. Images were captured using a Zeiss 
Axiplan 2 upright microscope (Intelligent Imaging Innovations, Inc., Denver, CO) and 
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Slidebook Software v2.0 (Intelligent Imaging Innovations, Inc., Denver, CO) for Oil Red O 
stained sections, a Leica TCS SP5 AOBS Resonant Scanning Multiphoton Confocal 
microscope and Leica LAS AF Lite 2.0.2 Build 2038 (Leica Microsystems, Buffalo Grove, 
IL) for colocalization IHC, all housed in the Cell Biology and Bioimaging Core at the 
PBRC. Image analyses were conducted using ImageJ software (MacBiophotonics, Bethesda, 
Maryland, USA) using the count plugin, analyze particles plugin or threshold functions, as 
necessary.
2.6 Statistical Analysis
Data were analyzed using the SAS software package (SAS V9, SAS Institute) using one-
way or two-way ANOVA, or repeated measures ANOVA, using the general linear model 
procedure. When experiment-wide tests were significant, post-hoc comparisons were made 
using the LSMEANS statement with the PDIFF option, and represent least significant 
differences tests for pre-planned comparisons. Energy expenditure was first normalized to 
body weight and then assessed via repeated measures ANOVA. EE was also analyzed via 
analysis of covariance (ANCOVA) with body weight as the covariate using the general linear 
model procedure of SAS, with results validated against the MMPC.org ANCOVA data 
analysis tool. All data are expressed as mean ± SEM, with a probability value of 0.05 
considered statistically significant.
3. Results
3.1 Protein restriction increases food intake and energy expenditure without influencing 
weight gain
Rats placed on a low protein (LP) diet exhibited an abrupt and significant increase in food 
intake that persisted for the duration of the experiment (Fig 1A). This increase in food intake 
was matched with a significant increase in energy expenditure (EE) but no difference in 
respiratory exchange ratio (Control: 0.95 ± 0.01 vs LP: 0.96 ± 0.01; P = 0.55). Increased 
energy expenditure was apparent regardless of whether the data were normalized to total 
body mass (Fig 1C, D), analyzed via analysis of covariance with body weight as the 
covariate (Fig 1E,F), or expressed on a per animal basis (data not shown). The concomitant 
increase in both food intake and energy expenditure resulted in no difference in body weight 
gain (Fig 1G) between control and LP rats over the 14 day period, although there was a 
significant increase in fat and fluid but not lean mass gain in LP compared to control (Fig 
1H,I,J.
3.2 Protein restriction induces hepatic autophagy
Following 14 days of control or LP diet, rats were sacrificed and livers collected to assess 
metabolic endpoints. To test whether LP induces hepatic autophagy, we first measured 
hepatic ATG5 protein and ATG5-ATG12 conjugation. Although there was no significant 
increase in ATG5 at day 14 of feeding, a significant increase in the ATG5-ATG12 complex, 
a marker of autophagosome formation, was observed in LP compared to control (Fig. 2A). 
LP livers also exhibited increased levels of LC3B, an additional marker of autophagy (Fig 
2B). Interestingly within the liver of LP rats, LC3B protein colocalized with the 
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mitochondrial marker COX IV (Fig. 2C), suggesting that mitochondria may be specifically 
targeted by LP-induced autophagy.
3.3 Protein restriction alters hepatic metabolism
Autophagy is associated with both the turnover of mitochondria and the regulation of lipid 
metabolism [4, 7]. In assessing the expression of several metabolic genes in the liver, we 
detected a LP-induced reduction in genes associated with lipogenesis, most notably Scd-1, 
Fas and Srebp1c (Fig 3A). This reduction in lipogenic gene expression was associated with a 
trend toward reduced hepatic lipid content as measured by oil red O staining (Fig 3B) or 
total liver triglyceride (Fig 3C), although these changes did not reach statistical significance. 
Finally, LP induced a significant reduction in mitochondrial DNA content (Fig 3D), 
consistent with evidence that autophagy promotes the turnover of mitochondria and our 
evidence for increased colocalization of LC3B with the mitochondrial marker COX IV.
3.4 Induction of hepatic autophagy during protein restriction is impaired in BCL2-AAA 
mice
Since dietary protein restriction induced autophagy in association with alterations in 
metabolic parameters, we next tested whether LP-induced autophagy was required for the 
metabolic responses to protein restriction. BCL2 plays a key role in the induction of 
autophagy in response to various stimuli such as starvation, and BCL2-AAA mice bear a 
series of mutations within BCL2 that prevent its phosphorylation [11]. Thus baseline 
autophagy is intact in these mice, but the induction to autophagy in response to starvation or 
exercise is impaired. To first confirm that the BCL2-AAA mutation impairs the LP-induced 
increase in hepatic autophagy, we placed wildtype (WT) or BCL2-AAA mice on control or 
LP diet for 14 days and collected liver to assess autophagy induction via an autophagy flux 
assay. Fresh liver samples were incubated with lysosomal inhibitors (NH4Cl and leupeptin) 
for 2hrs, and the accumulation of LC3 with addition of the lysosomal inhibitor was used as a 
marker of autophagy flux (Fig 4A and 4B). In WT mice, there was no consistent change in 
LC3 accumulation in mice consuming control diet, but in the WT-LP group every animal 
exhibited increases in LC3 content in liver samples incubated with lysosomal inhibitor, 
strongly suggesting that autophagy flux was increased by LP diet (Fig 4C). Importantly, this 
LP-induced increase in hepatic autophagy was absent in the BCL2-AAA mice consuming 
LP diet, indicating that the BCL2-AAA mutation effectively attenuates the induction of 
autophagy during dietary protein restriction.
3.5 Impaired autophagy potentiates the effect of LP diet on EE and food intake
Consistent with prior observations in rats (Fig 1) and mice [8], the LP diet induced a 
significant increase in EE (Fig 5A), with this increase occurring approximately 3 days 
following dietary exposure. Unexpectedly, this LP-induced increase in EE was exaggerated 
in BCL2-AAA mice (Fig 5B and 5C). Consistent with the changes in EE, food intake was 
also increased by the LP diet in WT mice, and this effect was again exaggerated in BCL2-
AAA mice on LP diet compared to BCL2-AAA on control diet (Fig 6A). As a result, the 
effect of LP on body weight gain was similar between WT and BCL2-AAA mice, as LP diet 
reduced body weight and lean gain but not fat gain in both WT and BCL2-AAA equally 
when compared to control animals (Fig 6B, C and D). Collectively, these data suggest that 
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the lack of LP-induced autophagy in BCL2-AAA mice exaggerates the adaptive changes in 
food intake and EE in response to protein restriction.
3.6 Impaired autophagy blocks the effect of LP diet on hepatic lipogenic expression and 
mitochondrial DNA
Because protein restriction in rats reduced hepatic lipogenic gene expression and hepatic 
mitochondrial DNA content, we next tested whether these effects would be altered in the 
absence of LP-induced autophagy. Consistent with our prior work, the LP diet reduced 
hepatic lipogenic gene expression and mitochondrial DNA content in WT mice (Fig 7); 
however, these effects were largely abolished in BCL2-AAA mice. These data suggest that 
autophagy plays a key role in regulating mitochondrial turnover and lipogenic gene 
expression in the liver during dietary protein restriction.
4. DISCUSSION
The data presented here are consistent with previous work demonstrating that dietary protein 
restriction induces a series of behavioral and metabolic changes, including increases in food 
intake, increases in energy expenditure, and alterations in hepatic metabolism [8, 9, 14, 15]. 
Importantly, these metabolic changes are associated with an increase in hepatic autophagy. It 
is well known that amino acid restriction induces autophagy in vitro [1–3], and that 
autophagy in the liver is induced by acute amino acid deprivation [16]. However, few studies 
have specifically tested whether autophagy is required for the metabolic response to protein 
restriction, particularly changes in whole animal feeding behavior and energy expenditure. 
The data presented here not only demonstrate that dietary protein restriction in the absence 
of energy restriction is sufficient to induce hepatic autophagy, these data also indicate that 
autophagy is a mediator of the metabolic effects of protein restriction.
Our work uses several approaches to demonstrate LP-induced hepatic autophagy. First, we 
demonstrate that protein restriction promotes the conjugation of ATG5 and ATG12. This 
ubiquitin-like conjugation event is required for autophagosome formation, and deletion or 
overexpression of ATG5 blocks or activates autophagy, respectively [6, 7, 17]. Second, we 
demonstrate the accumulation of LC3B protein, another marker of autophagosome 
accumulation, and in addition provide evidence that protein restriction promotes the 
subcellular colocalization of LC3B with the mitochondrial marker Cox IV. We also measure 
autophagy flux by testing the differential accumulation of LC3 in the presence or absence of 
lysosomal inhibitors ex vivo [18]. Importantly, this LP-induced increase in autophagic flux 
is lost in BCL2-AAA mice. The phosphorylation of BCL2 contributes to the induction of 
autophagy in response to various stimuli, and it has been previously shown that starvation or 
exercise-induced autophagy is impaired in these mice [11]. Here we demonstrate the failure 
of dietary protein restriction to induce hepatic autophagy within this model as well. These 
mice therefore provide a very unique model to test the effects of protein restriction on 
metabolic outcomes, because baseline autophagy is intact but the induction of autophagy in 
response to stimuli such as protein restriction is impaired.
Consistent with previous work by our group and others [8, 9, 12, 14, 15, 19–22], we 
observed rapid and persistent increases in food intake and energy expenditure when mice or 
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rats were placed on a LP diet. Interestingly, these effects were not lost but instead enhanced 
in the autophagy-deficient BCL2-AAA mice. Currently it is unclear why inhibition of 
autophagy produced this enhanced response. Autophagy provides a rapid and efficient 
mechanism to release cellular amino acids in response to protein restriction, and therefore 
one possibility is that more energy intensive metabolic pathways (such as proteasome-
dependent protein turnover) were recruited to meet physiological demands in the absence of 
autophagy, ultimately leading to increased energy expenditure which was offset by an 
increase in food intake. Alternatively, it is possible that the loss of autophagy triggered 
adaptive increases in food intake directly. For instance, it is possible that impaired autophagy 
lead to alterations in circulating amino acid concentrations, with these changes being sensed 
by the brain and promoting hyperphagia. It is well known that increases in leucine signaling 
within the brain are sufficient to suppress food intake and may contribute to reductions in 
food intake on a high protein diet [9, 12, 23–27]. However, we have tested whether 
fluctuations in circulating or brain amino acid signaling are necessary for LP-induced 
hyperphagia, and our results suggest that a fall of circulating leucine or BCAAs is not 
required for the observed hyperphagia [9].
These changes in whole body energy metabolism were associated with metabolic effects in 
the liver, including reduced hepatic lipogenic gene expression and a trend toward reduced 
hepatic lipid content. We emphasize that the control group consisted of young, low fat-fed 
rats with low hepatic lipid content, and thus our ability to detect further reductions in lipid 
content was likely limited. It will be interesting in future studies to test whether protein 
restriction reduces hepatic lipid content in the context of obesity, and it is noteworthy that a 
model of dietary methionine restriction produces similar reductions in hepatic lipogenic 
gene expression and hepatic lipid content [28, 29]. Importantly, our data also demonstrate 
that LP-induced autophagy contributes to several of these metabolic responses, as LP-
induced reductions in hepatic lipogenenic gene expression and mitochondrial DNA content 
were lost in the autophagy defective BCL2-AAA mice. These observations are consistent 
with evidence that autophagy is essential for the turnover of organelles, including 
mitochondria [30, 31], as well as evidence linking autophagy with fatty acid synthesis and 
lipid accumulation in the liver [4, 5, 7, 32, 33]. Considering that mitochondria play a critical 
role in balancing lipid synthesis and oxidation and that mitochondrial dysfunction may 
contribute to the onset and progression of obesity and insulin resistance [34, 35], these data 
suggest that the autophagy-induced turnover of mitochondria within the liver may be a key 
effect of dietary protein restriction.
In addition to changes in hepatic metabolism, it should be noted that the BCL2-AAA 
mutation is not specific for the liver in this mouse line. As such, it is possible that alterations 
in autophagy and/or metabolism within tissues such as adipose tissue or muscle may also 
contribute to the phenotype of BCL2-AAA mice on the LP diet. It is also possible that other 
signaling pathways may play an important role in the adaptive response to protein 
restriction. For instance, mTOR signaling is an important sensor of amino acid availability 
and a well-known regulator autophagy, while protein restriction also activates the integrated 
stress response via the kinase GCN2 [8, 36, 37]. Considering that these pathways are highly 
integrated within the cell, it seems likely that additional signaling systems beyond hepatic 
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autophagy are contributing to the diverse metabolic responses to protein restriction [1–3, 38–
40]
Our data provide clear evidence that dietary protein restriction induces significant changes in 
both whole body and liver metabolism, that hepatic autophagy can be triggered by dietary 
protein restriction, and that this induction of autophagy contributes to the metabolic 
responses to protein restriction. Autophagy is known to promote metabolic health and 
longevity [2, 6, 41], while protein restriction similarly triggers metabolic adaptations and 
promotes longevity [42]. When taken together, these data indicate that the induction of 
autophagy is an important component to the metabolic response to dietary protein 
restriction.
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1. Protein restriction induces adaptive changes in feeding behavior and 
metabolism.
2. Protein restriction induces autophagy within the liver.
3. Disruption of autophagy alters the metabolic response to protein restriction.
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Figure 1. Protein restriction increases food intake and EE in rats
Male rats were placed on control or low protein (LP) diets for 14 days. Food intake (A, B) 
was measured daily, while EE was measured in metabolic chambers for the first 7 days on 
diet (C). Average EE on days 5–7 was normalized to body weight (D) or analyzed via 
analysis of covariance (ANCOVA) with BW as the covariate (E, F). Body weight (G), fat 
(H), lean (I), and fluid (J) gain over the 14 day period. N=8. *P < 0.05 vs. Control.
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Figure 2. Protein restriction induces hepatic autophagy
Rat liver samples were collected following 14 days of control or LP diet. Induction of 
autophagy was determined via Western blot analysis of the conjugation of ATG5 to ATG12 
(A) and the increase of LC3B (B). The colocalization of LC3B with CoxIV was also 
increased by LP, suggesting the targeting of mitochondria to the autophagosome. N=8. *P < 
0.05 vs. Control.
Henagan et al. Page 14













Figure 3. Protein restriction alters hepatic metabolism
Rat liver samples were collected following 14 days of control or LP diet to assess metabolic 
gene expression (A), oil-red O staining (B) triglyceride content (C) and mitochondrial DNA 
content (D). N=8. *P < 0.05 vs. Control.
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Figure 4. Induction of hepatic autophagy in response to LP diet is impaired in BCL2-AAA mice
Wildtype and BCL2-AAA mice were placed on control or LP diet for 14 days. At sacrifice, 
liver samples were collected and assayed for autophagic flux. Representative blots of 
LC3A/B staining in the presence and absence of lysosomal inhibitors (A). Effect of inhibitor 
treatment on LC3A/B staining (B). Quantification of autophagy flux (fold induction with 
inhibitor), demonstrating loss of LP-induced hepatic autophagy in BCL2-AAA mice (C). 
N=7–8. *P < 0.05 vs. Control.
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Figure 5. Impaired autophagy potentiates the effect of LP diet on EE
Wildtype and BCL2-AAA mice were placed on control or LP diet for 14 days, with EE 
measured the first 7 days. LP increased EE in WT mice (A, C, D), and this effect was 
enhanced in BCL2-AAA mice (B, C, E). N=7–8. *P < 0.05 vs. Control. #P < 0.05 vs WT-
LP.
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Figure 6. Effects on LP diet on food intake and body weight gain
Wildtype and BCL2-AAA mice were placed on control or LP diet for 14 days. Food intake 
(A) throughout the 14 day experiment. Body weight gain (B), fat gain (C) and lean gain (D) 
were measured at day 14. N=7–8. *P < 0.05 vs. Control. #P < 0.05 vs WT-LP.
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Figure 7. Impaired autophagy blocks the hepatic response to LP diet
Wildtype and BCL2-AAA mice were placed on control or LP diet for 14 days. Loss of 
autophagy attenuated the effect of LP diet on liver gene expression (A), and also blocked the 
reduction of mitochondrial DNA content (B). N=7–8. *P < 0.05 vs. Control
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